ning xin agent clinical studies for the treatment of viral myocarditis in children(宁新剂治疗儿童病毒性心肌炎的临床研究).docVIP

  • 2
  • 0
  • 约1.25万字
  • 约 13页
  • 2017-09-05 发布于浙江
  • 举报

ning xin agent clinical studies for the treatment of viral myocarditis in children(宁新剂治疗儿童病毒性心肌炎的临床研究).doc

ning xin agent clinical studies for the treatment of viral myocarditis in children(宁新剂治疗儿童病毒性心肌炎的临床研究)

Ning Xin agent clinical studies for the treatment of viral myocarditis in children Abstract: Objective clinical validation Ning Mixture clinical efficacy for the treatment of viral myocarditis. Methods 90 patients were randomly divided into a treatment group, 60 patients Ning Xin mixture, Western medicine control group of 30 patients, mainly observed in children with symptoms, signs, electrocardiogram , enzymes and cardiac troponin results Ning Mixture effective treatment for children with viral myocarditis in children with symptoms and signs, has improvement arrhythmia, to reduce cardiac enzymes and cardiac troponin role, more effective than the comparison group, significant difference (P lt;0.05, no significant clinical adverse reactions. conclusion Ning Mixture compound Chinese medicine preparation of clinical treatment of viral myocarditis in children safely and effectively. Keywords: viral myocarditis in children, Ning heart Mixture, clinical research Viral myocarditis in pediatric clinical common diseases and frequently-occurring disease, the research group achieved significant clinical efficacy Ning Xin mixture in treating children with viral myocarditis 60 cases are as follows. 1 Clinical data 1.1 diagnostic standard Western diagnostic criteria reference lt;lt; gt;gt; pediatric disease diagnostic standard [1], September 1999 Kunming National viral myocarditis in children, the diagnosis of cardiomyopathy meeting revised program standards. Clinical diagnostic criteria: ○ cardiac function insufficiency, cardiac cardiogenic shock, or heart and brain syndrome. ○ enlarged heart (X-ray, echocardiography expressive one. ○ 3 ECG changes: R-wave-based two or more than two main leads (I, II, aVF, V5 ST-T changes associated with dynamic changes in the last four days, sinoatrial block, atrioventricular block, complete right or left bundle branch block, into bigeminy, multi-shaped, multi-source pairs or the parallelism premature, atopic non atrioventricu

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档